Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

New technologies to prevent intravascular catheter-related bloodstream infections.

Mermel LA.

Emerg Infect Dis. 2001 Mar-Apr;7(2):197-9. Review.

2.

Prevention of intravascular catheter-related infections.

Mermel LA.

Ann Intern Med. 2000 Mar 7;132(5):391-402. Erratum in: Ann Intern Med 2000 Sep 5;133(5):395.

PMID:
10691590
3.

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.

Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.

N Engl J Med. 1999 Jan 7;340(1):1-8.

4.
5.

Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.

Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D; Catheter-Related Infections in ICU (CRI-ICU) Group.

Crit Care Med. 2012 Feb;40(2):420-9. doi: 10.1097/CCM.0b013e31822f0d4b.

PMID:
21926583
6.

Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.

Marciante KD, Veenstra DL, Lipsky BA, Saint S.

Am J Infect Control. 2003 Feb;31(1):1-8.

PMID:
12548250
7.

Prevention of catheter-related infections: the skin.

Darouiche RO, Raad II.

Nutrition. 1997 Apr;13(4 Suppl):26S-29S. Review.

PMID:
9178307
8.
9.

Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.

Jaeger K, Zenz S, Jüttner B, Ruschulte H, Kuse E, Heine J, Piepenbrock S, Ganser A, Karthaus M.

Ann Hematol. 2005 Apr;84(4):258-62. Epub 2004 Nov 10.

PMID:
15549302
10.

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C.

Ann Intern Med. 1997 Aug 15;127(4):267-74.

PMID:
9265425
12.

A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.

Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, Whitby M, Graves N.

Am J Infect Control. 2008 Mar;36(2):104-17. doi: 10.1016/j.ajic.2007.02.012.

PMID:
18313512
13.

Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.

Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD.

JAMA. 1999 Jan 20;281(3):261-7.

PMID:
9918482
14.

The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters.

Safdar N, Maki DG.

Intensive Care Med. 2004 Jan;30(1):62-7. Epub 2003 Nov 26.

PMID:
14647886
15.

Decreasing catheter-related infection and hospital costs by continuous quality improvement.

Civetta JM, Hudson-Civetta J, Ball S.

Crit Care Med. 1996 Oct;24(10):1660-5.

PMID:
8874302
16.

Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.

Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II.

Ann Surg. 2005 Aug;242(2):193-200.

17.

Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.

Lorente L, Lecuona M, Jiménez A, Santacreu R, Raja L, Gonzalez O, Mora ML.

Am J Infect Control. 2014 Mar;42(3):321-4. doi: 10.1016/j.ajic.2013.09.022.

PMID:
24581021
18.

Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.

Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, Recio T, Generelo M, Ruiz-Ocaña F.

Intensive Care Med. 2004 Apr;30(4):633-8. Epub 2004 Jan 13.

PMID:
14722639
19.

Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention.

Safdar N, O'Horo JC, Maki DG.

J Hosp Infect. 2013 Nov;85(3):189-95. doi: 10.1016/j.jhin.2013.06.018. Epub 2013 Sep 23.

PMID:
24070632
20.

Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access.

Lorente L, Lecuona M, Jiménez A, Lorenzo L, Diosdado S, Marca L, Mora ML.

Am J Infect Control. 2014 Oct;42(10):1130-2. doi: 10.1016/j.ajic.2014.06.027.

PMID:
25278411

Supplemental Content

Support Center